178 related articles for article (PubMed ID: 30395635)
1. Economic and epidemiologic impact of guidelines for early ART initiation irrespective of CD4 count in Spain.
Kasaie P; Radford M; Kapoor S; Jung Y; Hernandez Novoa B; Dowdy D; Shah M
PLoS One; 2018; 13(11):e0206755. PubMed ID: 30395635
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Côte d'Ivoire: A model-based analysis.
Ouattara EN; MacLean RL; Danel C; Borre ED; Gabillard D; Huang M; Moh R; Paltiel AD; Eholié SP; Walensky RP; Anglaret X; Freedberg KA
PLoS One; 2019; 14(6):e0219068. PubMed ID: 31247009
[TBL] [Abstract][Full Text] [Related]
3. When to start antiretroviral therapy in resource-limited settings.
Walensky RP; Wolf LL; Wood R; Fofana MO; Freedberg KA; Martinson NA; Paltiel AD; Anglaret X; Weinstein MC; Losina E;
Ann Intern Med; 2009 Aug; 151(3):157-66. PubMed ID: 19620143
[TBL] [Abstract][Full Text] [Related]
4. Optimal frequency of CD4 cell count and HIV RNA monitoring prior to initiation of antiretroviral therapy in HIV-infected patients.
Kimmel AD; Goldie SJ; Walensky RP; Losina E; Weinstein MC; Paltiel AD; Zhang H; Freedberg KA;
Antivir Ther; 2005; 10(1):41-52. PubMed ID: 15751762
[TBL] [Abstract][Full Text] [Related]
5. Late HIV Diagnosis but Earlier Antiretroviral Treatment Initiation in Northwest Spain: Impact of Current Treatment Guidelines.
Cid-Silva P; Margusino-Framiñán L; Balboa-Barreiro V; Pernas-Souto B; Mena-De-Cea Á; Martín-Herranz I; Castro-Iglesias Á; Poveda E
J Int Assoc Provid AIDS Care; 2019; 18():2325958218821940. PubMed ID: 30798655
[TBL] [Abstract][Full Text] [Related]
6. Economic and epidemiological impact of early antiretroviral therapy initiation in India.
Maddali MV; Dowdy DW; Gupta A; Shah M
J Int AIDS Soc; 2015; 18(1):20217. PubMed ID: 26434780
[TBL] [Abstract][Full Text] [Related]
7. Early antiretroviral therapy for patients with acute aids-related opportunistic infections: a cost-effectiveness analysis of ACTG A5164.
Sax PE; Sloan CE; Schackman BR; Grant PM; Rong J; Zolopa AR; Powderly W; Losina E; Freedberg KA;
HIV Clin Trials; 2010; 11(5):248-59. PubMed ID: 21126955
[TBL] [Abstract][Full Text] [Related]
8. The Epidemiologic and Economic Impact of Improving HIV Testing, Linkage, and Retention in Care in the United States.
Shah M; Risher K; Berry SA; Dowdy DW
Clin Infect Dis; 2016 Jan; 62(2):220-229. PubMed ID: 26362321
[TBL] [Abstract][Full Text] [Related]
9. The cost-effectiveness of prophylaxis strategies for individuals with advanced HIV starting treatment in Africa.
Walker SM; Cox E; Revill P; Musiime V; Bwakura-Dangarembizi M; Mallewa J; Cheruiyot P; Maitland K; Ford N; Gibb DM; Walker AS; Soares M;
J Int AIDS Soc; 2020 Mar; 23(3):e25469. PubMed ID: 32219991
[TBL] [Abstract][Full Text] [Related]
10. Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050.
Granich R; Kahn JG; Bennett R; Holmes CB; Garg N; Serenata C; Sabin ML; Makhlouf-Obermeyer C; De Filippo Mack C; Williams P; Jones L; Smyth C; Kutch KA; Ying-Ru L; Vitoria M; Souteyrand Y; Crowley S; Korenromp EL; Williams BG
PLoS One; 2012; 7(2):e30216. PubMed ID: 22348000
[TBL] [Abstract][Full Text] [Related]
11. Newer drugs and earlier treatment: impact on lifetime cost of care for HIV-infected adults.
Sloan CE; Champenois K; Choisy P; Losina E; Walensky RP; Schackman BR; Ajana F; Melliez H; Paltiel AD; Freedberg KA; Yazdanpanah Y;
AIDS; 2012 Jan; 26(1):45-56. PubMed ID: 22008655
[TBL] [Abstract][Full Text] [Related]
12. HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa.
Eaton JW; Johnson LF; Salomon JA; Bärnighausen T; Bendavid E; Bershteyn A; Bloom DE; Cambiano V; Fraser C; Hontelez JA; Humair S; Klein DJ; Long EF; Phillips AN; Pretorius C; Stover J; Wenger EA; Williams BG; Hallett TB
PLoS Med; 2012; 9(7):e1001245. PubMed ID: 22802730
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of antiretroviral therapy expansion strategies in Vietnam.
Tran DA; Wilson DP; Shakeshaft A; Ngo AD; Reyes J; Doran C; Zhang L
AIDS Patient Care STDS; 2014 Jul; 28(7):365-71. PubMed ID: 24983389
[TBL] [Abstract][Full Text] [Related]
14. The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States.
Long EF; Brandeau ML; Owens DK
Ann Intern Med; 2010 Dec; 153(12):778-89. PubMed ID: 21173412
[TBL] [Abstract][Full Text] [Related]
15. Estimated Costs for Delivery of HIV Antiretroviral Therapy to Individuals with CD4+ T-Cell Counts >350 cells/uL in Rural Uganda.
Jain V; Chang W; Byonanebye DM; Owaraganise A; Twinomuhwezi E; Amanyire G; Black D; Marseille E; Kamya MR; Havlir DV; Kahn JG
PLoS One; 2015; 10(12):e0143433. PubMed ID: 26632823
[TBL] [Abstract][Full Text] [Related]
16. [Budget impact analysis of antiretroviral therapy. A reflection based on the GESIDA guidelines].
Grupo de trabajo de la Cohorte VACH
Gac Sanit; 2012; 26(6):541-6. PubMed ID: 22498716
[TBL] [Abstract][Full Text] [Related]
17. Laboratory Monitoring of Antiretroviral Therapy for HIV Infection: Cost-Effectiveness and Budget Impact of Current and Novel Strategies.
Ouattara EN; Robine M; Eholié SP; MacLean RL; Moh R; Losina E; Gabillard D; Paltiel AD; Danel C; Walensky RP; Anglaret X; Freedberg KA
Clin Infect Dis; 2016 Jun; 62(11):1454-1462. PubMed ID: 26936666
[TBL] [Abstract][Full Text] [Related]
18. Health outcomes and cost impact of the new WHO 2013 guidelines on prevention of mother-to-child transmission of HIV in Zambia.
Ishikawa N; Shimbo T; Miyano S; Sikazwe I; Mwango A; Ghidinelli MN; Syakantu G
PLoS One; 2014; 9(3):e90991. PubMed ID: 24604067
[TBL] [Abstract][Full Text] [Related]
19. The Cost-Effectiveness of Human Immunodeficiency Virus Testing and Treatment Engagement Initiatives in British Columbia, Canada: 2011-2013.
Nosyk B; Min JE; Krebs E; Zang X; Compton M; Gustafson R; Barrios R; Montaner JSG;
Clin Infect Dis; 2018 Feb; 66(5):765-777. PubMed ID: 29028964
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of Frequent HIV Screening Among High-risk Young Men Who Have Sex With Men in the United States.
Neilan AM; Bulteel AJB; Hosek SG; Foote JHA; Freedberg KA; Landovitz RJ; Walensky RP; Resch SC; Kazemian P; Paltiel AD; Weinstein MC; Wilson CM; Ciaranello AL
Clin Infect Dis; 2021 Oct; 73(7):e1927-e1935. PubMed ID: 32730625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
